<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Br J Pharmacol</journal-id>
<journal-id journal-id-type="iso-abbrev">Br. J. Pharmacol</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1476-5381</journal-id>
<journal-id journal-id-type="publisher-id">BPH</journal-id>
<journal-title-group>
<journal-title>British Journal of Pharmacology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0007-1188</issn>
<issn pub-type="epub">1476-5381</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29161771</article-id>
<article-id pub-id-type="pmc">5773967</article-id>
<article-id pub-id-type="doi">10.1111/bph.14102</article-id>
<article-id pub-id-type="publisher-id">BPH14102</article-id>
<article-id pub-id-type="other">2017-BJP-1050-RP.R2</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Research Paper</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Research Papers</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Tetramethylpyrazine nitrone activates the BDNF/Akt/CREB pathway to promote post‐ischaemic neuroregeneration and recovery of neurological functions in rats</article-title>
<alt-title alt-title-type="right-running-head">TBN promotes neurogenesis after ischaemic stroke</alt-title>
<alt-title alt-title-type="left-running-head">G Zhang et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="bph14102-cr-0001">
<name>
<surname>Zhang</surname>
<given-names>Gaoxiao</given-names>
</name>
<xref ref-type="aff" rid="bph14102-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="bph14102-note-0001">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph14102-cr-0002">
<name>
<surname>Zhang</surname>
<given-names>Tao</given-names>
</name>
<xref ref-type="aff" rid="bph14102-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="bph14102-note-0001">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph14102-cr-0003">
<name>
<surname>Li</surname>
<given-names>Ning</given-names>
</name>
<xref ref-type="aff" rid="bph14102-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph14102-cr-0004">
<name>
<surname>Wu</surname>
<given-names>Liangmiao</given-names>
</name>
<xref ref-type="aff" rid="bph14102-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph14102-cr-0005">
<name>
<surname>Gu</surname>
<given-names>Jianbo</given-names>
</name>
<xref ref-type="aff" rid="bph14102-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="bph14102-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph14102-cr-0006">
<name>
<surname>Li</surname>
<given-names>Cuimei</given-names>
</name>
<xref ref-type="aff" rid="bph14102-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph14102-cr-0007">
<name>
<surname>Zhao</surname>
<given-names>Chen</given-names>
</name>
<xref ref-type="aff" rid="bph14102-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph14102-cr-0008">
<name>
<surname>Liu</surname>
<given-names>Wei</given-names>
</name>
<xref ref-type="aff" rid="bph14102-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph14102-cr-0009">
<name>
<surname>Shan</surname>
<given-names>Luchen</given-names>
</name>
<xref ref-type="aff" rid="bph14102-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph14102-cr-0010">
<name>
<surname>Yu</surname>
<given-names>Pei</given-names>
</name>
<xref ref-type="aff" rid="bph14102-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph14102-cr-0011">
<name>
<surname>Yang</surname>
<given-names>Xifei</given-names>
</name>
<xref ref-type="aff" rid="bph14102-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph14102-cr-0012">
<name>
<surname>Tang</surname>
<given-names>Yaohui</given-names>
</name>
<xref ref-type="aff" rid="bph14102-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph14102-cr-0013">
<name>
<surname>Yang</surname>
<given-names>Guo‐Yuan</given-names>
</name>
<xref ref-type="aff" rid="bph14102-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph14102-cr-0014">
<name>
<surname>Wang</surname>
<given-names>Yuqiang</given-names>
</name>
<xref ref-type="aff" rid="bph14102-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="bph14102-cr-0015">
<name>
<surname>Sun</surname>
<given-names>Yewei</given-names>
</name>
<address>
<email>yxy0723@163.com</email>
</address>
<xref ref-type="aff" rid="bph14102-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="bph14102-cr-0016">
<name>
<surname>Zhang</surname>
<given-names>Zaijun</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0690-1673</contrib-id>
<address>
<email>zaijunzhang@163.com</email>
</address>
<xref ref-type="aff" rid="bph14102-aff-0001">
<sup>1</sup>
</xref>
</contrib>
</contrib-group>
<aff id="bph14102-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Institute of New Drug Research and Guangzhou Key Laboratory of Innovative Chemical Drug Research in Cardio‐cerebrovascular Diseases</named-content>
<institution>Jinan University College of Pharmacy</institution>
<named-content content-type="city">Guangzhou</named-content>
<country country="CN">China</country>
</aff>
<aff content-type="private-address" id="bph14102-aff-0002">
<label><sup>2</sup></label>
<institution>Guangzhou Magpie Pharmaceuticals Co., LTD.</institution>
<named-content content-type="city">Guangzhou</named-content>
<country country="CN">China</country>
</aff>
<aff content-type="private-address" id="bph14102-aff-0003">
<label><sup>3</sup></label>
<institution>Key Laboratory of Modern Toxicology of Shenzhen, Center for Disease Control and Prevention</institution>
<named-content content-type="city">Shenzhen</named-content>
<country country="CN">China</country>
</aff>
<aff id="bph14102-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Neuroscience and Neuroengineering Center, Med‐X Research Institute and School of Biomedical Engineering</named-content>
<institution>Shanghai Jiao Tong University</institution>
<named-content content-type="city">Shanghai</named-content>
<country country="CN">China</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold> Zaijun Zhang and Yewei Sun, Institute of New Drug Research and Guangzhou Key Laboratory of Innovative Chemical Drug Research in Cardio‐cerebrovascular Diseases, Jinan University College of Pharmacy, Guangzhou 510632, China. E‐mail: <email>zaijunzhang@163.com</email>; <email>yxy0723@163.com</email><break></break></corresp>
<fn id="bph14102-note-0001">
<label>†</label>
<p>These authors contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>22</day>
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>2</month>
<year>2018</year>
</pub-date>
<volume>175</volume>
<issue>3</issue>
<issue-id pub-id-type="doi">10.1111/bph.v175.3</issue-id>
<fpage>517</fpage>
<lpage>531</lpage>
<history>
<date date-type="received">
<day>13</day>
<month>8</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>02</day>
<month>11</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>11</month>
<year>2017</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2018 The British Pharmacological Society <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2017 The British Pharmacological Society</copyright-statement>
</permissions>
<self-uri content-type="pdf" xlink:href="file:BPH-175-517.pdf" xlink:type="simple"></self-uri>
<abstract>
<sec id="bph14102-sec-0001">
<title>Background and Purpose</title>
<p>Neuronal regeneration from endogenous precursors is an attractive strategy for the treatment of ischaemic stroke. However, most stroke‐generated newborn neurons die over time. Therefore, a drug that is both neuroprotective and pro‐neurogenic may be beneficial after stroke. Here, we assessed the neurogenic and oligodendrogenic effects of tetramethylpyrazine nitrone (TBN), a neuroprotective drug candidate for stroke, in a rat model of ischaemic stroke.</p>
</sec>
<sec id="bph14102-sec-0002">
<title>Experimental Approach</title>
<p>We used Sprague Dawley rats with middle cerebral artery occlusion (MCAO). TBN was administered by tail vein injection beginning at 3 h post ischaemia. Therapeutic effect of TBN was evaluated by neurological behaviour and cerebral infarction. Promotion of neurogenesis and oligodendrogenesis was determined by double immunofluorescent staining and Western blotting analyses. Primary cultures of cortical neurons were used to assess the effect of TBN on neuronal differentiation <italic>in vitro.</italic>
</p>
</sec>
<sec id="bph14102-sec-0003">
<title>Key Results</title>
<p>TBN reduced cerebral infarction, preserved and/or restored neurological function and promoted neurogenesis and oligodendrogenesis in rats after MCAO. In addition, TBN stimulated neuronal differentiation on primary culture of cortical neurons <italic>in vitro</italic>. Pro‐neurogenic effects of TBN were attributed to its activation of the AKT/cAMP responsive element‐binding protein through increasing brain‐derived neurotrophic factor (BDNF) expression, as shown by the abolition of the effects of TBN by a specific inhibitor of BDNF receptor ANA‐12 and by the PI3K inhibitor LY294002.</p>
</sec>
<sec id="bph14102-sec-0004">
<title>Conclusion and Implications</title>
<p>As TBN can simultaneously provide neuroprotection and pro‐neurogenic effects, it may be a promising treatment for both acute phase neuroprotection and long‐term functional recovery after ischaemic stroke.</p>
</sec>
</abstract>
<funding-group>
<award-group>
<funding-source>Fundamental Research Funds for the Central Universities</funding-source>
<award-id>21617469</award-id>
</award-group>
<award-group>
<funding-source>Science and Technology Program of Guangzhou</funding-source>
<award-id>201704020181</award-id>
</award-group>
<award-group>
<funding-source>National Science Foundation of China</funding-source>
<award-id>81502908</award-id>
</award-group>
<award-group>
<funding-source>GD‐HK Cooperative Project</funding-source>
<award-id>2016A050503030</award-id>
</award-group>
<award-group>
<funding-source>Scientific Projects of Guangdong Province</funding-source>
<award-id>2013A022100030</award-id>
<award-id>2014A030310174</award-id>
<award-id>2015A020211019</award-id>
<award-id>2015B020232011</award-id>
<award-id>2016A020217013</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="7"></fig-count>
<table-count count="0"></table-count>
<page-count count="15"></page-count>
<word-count count="7537"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>bph14102</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>February 2018</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.3.1 mode:remove_FC converted:19.01.2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="bph14102-cit-0000" publication-type="journal">
<string-name>
<surname>Zhang</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Li</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Wu</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Gu</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Li</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<surname>Shan</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Yu</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Yang</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Tang</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Yang</surname>, <given-names>G.‐Y.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Sun</surname>, <given-names>Y.</given-names>
</string-name>, and <string-name>
<surname>Zhang</surname>, <given-names>Z.</given-names>
</string-name> (<year>2018</year>) <article-title>Tetramethylpyrazine nitrone activates the BDNF/Akt/CREB pathway to promote post‐ischaemic neuroregeneration and recovery of neurological functions in rats</article-title>. <source/>British Journal of Pharmacology, <volume>175</volume>: <fpage>517</fpage>–<lpage>531</lpage>. doi: <ext-link ext-link-type="doi" xlink:href="10.1111/bph.14102">10.1111/bph.14102</ext-link>.</mixed-citation>
</p>
</notes>
</front>
</article>
</pmc-articleset>